Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
- Status
- TERMINATED
- Phase
- PHASE3
Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
- Status
- COMPLETED
- Phase
- PHASE3
Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE4
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
- Status
- TERMINATED
- Phase
- PHASE4
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
- Status
- COMPLETED
- Phase
- PHASE4
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
- Status
- TERMINATED
- Phase
- PHASE4
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole in the Treatment of Severe and Recurrent Endometriosis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.
- Status
- COMPLETED
- Phase
- PHASE3